Govt Job for M.Pharm to work in ICMR funded project

The Birla Institute of Technology & Science, BITS Pilani is an all-India Institute for higher education. The primary motive of BITS is to “train young men and women able and eager to create and put into action such ideas, methods, techniques and information”.

The Institute is a dream come true of its founder late Mr G.D.Birla – an eminent industrialist, a participant in Indian freedom struggle and a close associate of the Father of Indian Nation late Mr. Mohandas Karamchand Gandhi (Mahatma Gandhi).

Applications are invited from suitable candidates for Junior Research Fellow (JRF) to work on the following project sponsored by ICMR, under the supervision of Prof. Rajeev Taliyan, Department of Pharmacy, BITS-Pilani, Pilani Campus, Rajasthan

Title of the project : Exploring the mechanism(s) of gut microbiota link to Parkinson Disease pathology and its reversal based on fibroblast growth factor 21 gene delivery through lentivirus system

Fellowship amount : 31000/- per month

Eligibility requirements : M.Pharm / M.S. (Pharm.) in Pharmacology / Pharmaceutics, Pharmaceutical technology and Pharm. Analysis with GATE / GPAT / CSIR-NET / DST-INSPIRE or equivalent examination.

Duration of the project : 03 Years

Interested candidates with the above mentioned qualification can send the applications on a plain paper giving detailed information about the educational qualifications, research experience and published research papers if any via email by 18th January 2021 to the Principal Investigator, Prof .Rajeev Taliyan [Email: rajeev.taliyan@pilani.bits-pilani.ac.in].

Please note that only qualified and suitable candidates will be called for online interview to be held by end of 3rd week of January 2021 and no TA/DA will be paid for the interview. Selected candidate may be permitted to register for Ph.D programme of BITS, Pilani, subject to the fulfillment of the requirements.

PI : Dr. Rajeev Taliyan (Associate Professor)

Related Posts

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

New Delhi: Aurobindo Pharma Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic version of glycerol phenylbutyrate oral liquid…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal, Ajinomoto team on ADC development and manufacturing

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Cancer cure must not be hostage to Big Pharma

Cancer cure must not be hostage to Big Pharma

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India